Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Psychophysical Studies of Cancer Therapy Pain

for
Advanced Cancer, Pain
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT00515060

Recruiting

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06565260

Recruiting

Phase I Human Analytics (HALO) Study

for
Cardiovascular Diseases, Cancer, Dementia,
Location: Indian Wells CA
Sponsor: HALO Diagnostics

Sex: Male

Age: 45 - 70+

Code: NCT05423860

Recruiting

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

for
Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05733091

Recruiting

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

for
Cancer, Predictive Cancer Model, Effects of Chemotherapy
Location: Durham NC, Rochester MN, Houston TX
Sponsor: Known Medicine, Inc.

Sex: All

Age: 18+

Code: NCT05338073

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life

for
Cancer, Head and Neck Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06667427

Recruiting

A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias

for
Refractory Acute Leukemia, Pediatric Relapsed
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 2 - 21

Code: NCT06397027

Phase 1, Recruiting

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

for
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05092373

Phase 1, Recruiting

A Study of BG-C477 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: New Haven CT, Hackensack NJ, Peoria IL, Jackson MS,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06596473

Phase 1, Recruiting

Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)

for
Cancer
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT05413473

Phase 1, Phase 2, Recruiting

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

for
Malignant Solid Neoplasm,
Location: Bethesda MD, Jacksonville FL, Rochester MN,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03750227

Phase 3, Recruiting

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

for
Solid Tumor, Adult
Location: Boston MA, New Haven CT, Pittsburgh PA, Orlando FL,
Sponsor: Ribon Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04053673

Phase 1, Recruiting

Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Scottsdale AZ
Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Sex: All

Age: 18+

Code: NCT03398720

Phase 1, Recruiting

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: New York NY, Pittsburgh PA
Sponsor: AskGene Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05867420

Phase 1, Phase 2, Recruiting

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

for
Lymphoma, Malignant Solid Neoplasm
Location: Lake Success NY, Chesapeake VA, Newark DE, Scranton PA,
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT05006482

Phase 3, Recruiting

Evaluation of Depression and Anxiety in Chemotherapy Patients

for
Oncology Problem
Location: Staten Island NY
Sponsor: Richmond University Medical Center

Sex: All

Age: 18 - 70+

Code: NCT03552731

Recruiting

Prospective Study of oncRNA Stratification of Cancer by Size and Stage

for
Cancer
Location: Reno NV, Palo Alto CA
Sponsor: Exai Bio Inc.

Sex: All

Age: 18+

Code: NCT05833360

Recruiting

Ovarian Tissue Freezing For Fertility Preservation

for
Malignancy, Fertility
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: Female

Age: 18 - 41

Code: NCT00902720

Recruiting

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

for
Advanced Malignant Solid Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT05705492

Phase 2, Recruiting

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

for
Solid Tumor
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 1 - 70

Code: NCT05238792

Phase 1, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial